This compilation includes all of our research to-date on the coronavirus. High frequency charts on infection, mortality, hospitalization and vaccination are updated as data becomes available, usually on a daily basis.
What’s new: Omicron variant (Section 5); and vaccinated vs unvaccinated infection, hospitalization and mortality rates (Section 1)
Our research to-date on the coronavirus: |
- “A pandemic (mostly) of the unvaccinated”: adverse outcomes in unvaccinated vs vaccinated people
- Vaccination update by country and state
- Variant prevalence by country
2. Global infection, hospitalization and mortality trends
- COVID trends for the US, Europe, South America, Asia, MidEast, Russia Region and Africa
- How lethal is COVID, and for whom? Tracking excess deaths in the US
3. Individual country and state charts
- Country and state specific charts on vaccination, infection, hospitalization and mortality
4. US pandemic economic impact tracker
- Real time credit and debit spending data
- High frequency tracking (air travel, hotels, etc.)
- Office utilization rates and mobility
5. The Omicron variant: what we know so far
- Latest news and data on the Omicron variant
- Update on Pfizer’s COVID antiviral pill Paxlovid
1. The US reopens: tracking US citizens and consumers
- High frequency recovery tracking (mobility, manufacturing, retail, air travel, geolocation, oil, hotels, housing, etc.)
- Real time credit and debit spending data
2. COVID global infection, hospitalization and mortality tracker
- Global COVID infection snapshot (trends, declines from peak levels, threshold levels)
- US hotspot tracking: infections, hospitalizations, mortality, testing and doctor visits
- Infection and mortality time series by country
3. COVID drug development (vaccines, antivirals, mAbs, steroids and blood thinners)
- What we know on the Pfizer/BioNTech vaccine news
- The latest news on anti-virals, vaccines, monoclonal antibodies, convalescent plasma and corticosteroids
- Potential benefits of anticoagulants, statins and ACE inhibitors for infected patients
- The latest news on anti-virals, vaccines, monoclonal antibodies, convalescent plasma and corticosteroids
- Potential benefits of anticoagulants, statins and ACE inhibitors for infected patients
5. COVID: testing for the virus and for antibodies, T-cell immune memory and survivor impacts
- How virus testing and antibody testing work
- Latest regional serology results and implications for higher levels of immunity
- Pre-existing T-cell immune memory and COVID
- The issue of falling antibody levels in convalescing patients
- COVID health impacts on survivors
6. Detailed virus reports by state
- One-page reports on each state with charts on infections, hospitalizations, mortality, testing levels, positive test rates, hospital bed/ICU utilization rates and doctor visit indicators
This compilation incorporates research and feedback from the Johns Hopkins University Center for Health Security, Harvard Medical School, the University of Toronto Dalla Lana School of Public Health, Washington University Biomedical Sciences Department, the La Jolla Institute for Immunology, the Imperial College of London Department of Infectious Disease Epidemiology and the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
0903c02a8283f910
